- Your Challenges
- News & Events
- Knowledge Center
- About Us
Contrast media can pose serious health risks to patients with chronic or acute renal insufficiency—including potentially fatal nephrogenic systemic fibrosis (NSF) or contrast-induced nephropathy (CIN).1
Creatinine measurement of renal function is recommended prior to administration of contrast media—especially for patients with risk factors such as diabetes, kidney impairment, and advanced age.2 Waiting for lab creatinine tests could take hours, disrupting the efficiency of the department or clinic.
REFERENCES1. FDA ALERT (6/2006, updated 12/2006 and 5/23/2007).
Links which take you out of Abbott worldwide websites are not under the control of Abbott, and Abbott is not responsible for the contents of any such site or any further links from such site. Abbott is providing these links to you only as a convenience, and the inclusion of any link does not imply endorsement of the linked site by Abbott. The website that you have requested also may not be optimised for your screen size.
Please be aware that the website you have requested is intended for the residents of a particular country or countries, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions.
The page you are trying to access is best viewed on a desktop or laptop computer.